Protalix BioTherapeutics (PLX) Cash from Investing Activities (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 479.77% |
| Dec 31, 2025 | -120.63% |
| Sep 30, 2025 | -15.07% |
| Jun 30, 2025 | -40.38% |
| Mar 31, 2025 | 97.96% |
| Dec 31, 2024 | -175.37% |
| Sep 30, 2024 | 11,392.78% |
| Jun 30, 2024 | 70.30% |
| Mar 31, 2024 | -77.19% |
| Dec 31, 2023 | 98.36% |
| Sep 30, 2023 | -9,304.95% |
| Jun 30, 2023 | -104.69% |
| Mar 31, 2023 | -4.46% |
| Dec 31, 2022 | -16.22% |
| Sep 30, 2022 | 1,556.02% |
| Jun 30, 2022 | 102.20% |
| Mar 31, 2022 | -143.43% |
| Dec 31, 2021 | 708.73% |
| Sep 30, 2021 | -38.61% |
| Jun 30, 2021 | 124.57% |
| Mar 31, 2021 | -504.16% |
| Dec 31, 2020 | -2.70% |
| Sep 30, 2020 | 3,011.57% |
| Jun 30, 2020 | 99.24% |
| Mar 31, 2020 | -121,062.07% |
| Dec 31, 2019 | 106.50% |
| Sep 30, 2019 | -369.47% |
| Jun 30, 2019 | 74.39% |
| Mar 31, 2019 | -541.67% |
| Dec 31, 2018 | 136.84% |
| Sep 30, 2018 | -91.60% |
| Jun 30, 2018 | 63.72% |
| Mar 31, 2018 | -864.71% |
| Dec 31, 2017 | 70.69% |
| Sep 30, 2017 | 83.09% |
| Jun 30, 2017 | -142.40% |
| Mar 31, 2017 | -16.94% |
| Dec 31, 2016 | -266.67% |
| Sep 30, 2016 | 81.97% |
| Jun 30, 2016 | -24.91% |
| Mar 31, 2016 | -100.73% |
| Dec 31, 2015 | 23,711.24% |
| Sep 30, 2015 | 31.85% |
| Jun 30, 2015 | -150.51% |
| Mar 31, 2014 | -36.53% |
| Dec 31, 2013 | 35.32% |
| Sep 30, 2013 | 42.05% |
| Jun 30, 2013 | -4.93% |
| Mar 31, 2013 | -83.24% |
| Dec 31, 2012 | 54.09% |
| Sep 30, 2012 | -242.68% |
| Jun 30, 2012 | 71.95% |
| Mar 31, 2012 | -14.06% |
| Dec 31, 2011 | 27.33% |
| Sep 30, 2011 | 28.76% |
| Jun 30, 2011 | 45.55% |
| Mar 31, 2011 | -146.51% |
| Dec 31, 2010 | 22.33% |